Intubating Conditions with Org NC 45: A Comparison with Suxamethonium and Pancuronium

[1]  R. Miller,et al.  Clinical Pharmacology of ORG NC45 (NorcuronTM): A New Nondepolarizing Muscle Relaxant , 1981, Anesthesiology.

[2]  J. Viby-Mogensen,et al.  Cardiac effects of atropine and gallamine in patients receiving suxamethonium. , 1980, British journal of anaesthesia.

[3]  D. Newton,et al.  The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study. , 1980, British journal of anaesthesia.

[4]  J. Engbaek,et al.  On ORG NC 45 and halothane anaesthesia. Preliminary results. , 1980, British journal of anaesthesia.

[5]  W. Erdmann,et al.  ANTAGONISM OF KETAMINE-DIAZEPAM ANAESTHESIA BY 4-AMINOPYRINDINE IN HUMAN VOLUNTEERS , 1980 .

[6]  Ronald D. Miller,et al.  Comparison of the Cardiovascular Actions of Org NC 45 with Those Produced By Other Non-Depolarizing Neuromuscular Blocking Agents in Experimental Animals , 1980 .

[7]  L. Booij,et al.  Pharmacology of ORG NC 45 compared with other non-depolarizing neuromuscular blocking drugs. , 1980, British journal of anaesthesia.

[8]  G. Hall,et al.  Porcine malignant hyperthermia. VII: Hepatic metabolism. , 1980, British journal of anaesthesia.

[9]  L. Booij,et al.  First clinical experiences with ORG NC 45. , 1980, British journal of anaesthesia.

[10]  G. Smith,et al.  Comparison of the effects of spinal anaesthesia and general anaesthesia on postoperative oxygenation and perioperative mortality. , 1980, British journal of anaesthesia.

[11]  J. Dundee,et al.  Intubating conditions with AH 8165 and suxamethonium , 1975, Anaesthesia.

[12]  I. Lund,et al.  EXPERIMENTAL AND CLINICAL EXPERIENCES WITH A NEW MUSCLE RELAXANT Ro 4–3816, DIALLYL‐NOR‐TOXIFERINE , 1962, Acta anaesthesiologica Scandinavica.